There is increasing evidence that -opioid receptor agonists modulate cocaine-maintained behavior, and limited findings implicate the involvement of -opioid receptors in ethanol-maintained behaviors. The purpose of the present study was to investigate the effects of bremazocine, a -opioid agonist, on the self-administration of smoked cocaine base and oral ethanol in rhesus monkeys (Macaca mulatta). To determine the selectivity of bremazocine, the effects of bremazocine pretreatment on the oral selfadministration of phencyclidine (PCP), saccharin, and food were also examined. Adult male rhesus monkeys were trained to selfadminister oral ethanol, PCP, saccharin (n ϭ 8), food (n ϭ 6), or smoked cocaine base (n ϭ 6) and water during daily sessions. Bremazocine (0.00032-, 0.001-, and 0.0025-mg/kg i.m.) injections were given 15 min before session. The 4 days of stable behavior before pretreatment served as baseline. Demand curves (consumption ϫ fixed ratio; FR) were obtained for smoked cocaine base, ethanol, and PCP by varying the cost (FR) of drug deliveries and measuring consumption (deliveries). Bremazocine (0.001 mg/ kg) was administered at each FR value in nonsystematic order. Results indicate that bremazocine dose dependently reduced cocaine, ethanol, PCP, and saccharin intake. Food intake was affected less by bremazocine than the other substances in five of the six monkeys. Generally, bremazocine treatment reduced the demand for cocaine, ethanol, and PCP as well as other measures of response strength. These results extend the findings that -agonists reduce the self-administration of drug and nondrug reinforcers to smoked cocaine base and oral ethanol, PCP, and saccharin in rhesus monkeys.Cocaine and alcohol abuse are well recognized psychiatric disorders with high rates of recidivism. Currently, there are few effective pharmacotherapies for the treatment of these disorders. However, recently -opioid receptor agonists have shown potential for the treatment of cocaine abuse, and limited evidence suggests that -agonists modulate ethanolmaintained behaviors (Nestby et al., 1999). It is increasingly evident that the mesolimbic dopamine system plays a role in mediating the reinforcing effects of psychostimulant drugs. It is well known that within this system, -and ␦-agonists stimulate and -agonists suppress dopaminergic neurotransmission (Herz, 1998), and it is likely that these opposing effects of -or ␦-and -opioid receptors within this system modulate drug-maintained behaviors. For example, the -opioid agonists U50488 and bremazocine reduced dopamine transmission in the mesolimbic dopamine system; whereas, -agonists stimulated dopamine transmission (Di Chiara and Imperato, 1988).It is generally accepted that -opioid receptors are involved in the neurobiological and behavioral effects of cocaine.-Agonists suppressed the increase in basal dopamine dialysate levels occurring during abstinence from cocaine (Heidbreder and Shippenberg, 1994;Chefer et al., 2000). The -agonist U69593 decreased basal rates of dopami...